Nitrative stress has an important role in microvascular degeneration leading to ischemia in conditions such as diabetic retinopathy and retinopathy of prematurity. Thus far, mediators of nitrative stress have been poorly characterized. We recently described that trans-arachidonic acids are major products of NO 2 -mediated isomerization of arachidonic acid within the cell membrane, but their biological relevance is unknown. Here we show that trans-arachidonic acids are generated in a model of retinal microangiopathy in vivo in a NO -dependent manner. They induce a selective time-and concentration-dependent apoptosis of microvascular endothelial cells in vitro, and result in retinal microvascular degeneration ex vivo and in vivo. These effects are mediated by an upregulation of the antiangiogenic factor thrombospondin-1, independently of classical arachidonic acid metabolism. Our findings provide new insight into the molecular mechanisms of nitrative stress in microvascular injury and suggest new therapeutic avenues in the management of disorders involving nitrative stress, such as ischemic retinopathies and encephalopathies.
Ischemia-induced proliferative retinopathies such as diabetic retinopathy and retinopathy of prematurity are characterized by microvascular degeneration and retinal ischemia, which can lead to secondary aberrant neovascularization, hemorrhages and blindness [1] [2] [3] . Several mechanisms involved in the loss of retinal vasculature have been identified. A downregulation of the proangiogenic vascular endothelial growth factor (VEGF) by hyperoxia or an inhibition of its receptor signaling leads to microvascular degeneration [4] [5] [6] [7] . Antiangiogenic factors, such as thrombospondin (TSP)-1 are also important because deletion of TSP-1 protects against oxygen-induced vaso-obliteration 8 . Oxygen-derived free radicals contribute to microvascular injury 2, 9 , and antioxidants inhibit microvascular degeneration in models of diabetic retinopathy 10 and oxygen-induced retinopathy (OIR) 2, 11, 12 . These reactive oxygen species can react with nitric oxide (NO ) to generate highly reactive nitrogen species 13 , including peroxynitrite, nitrogen dioxide (NO 2 ) and dinitrogen trioxide (N 2 O 3 ), whose deleterious effects on cell function are generally referred to as nitrative stress 14 . Several studies have indicated a crucial role for NO and ensuing nitrative stress in ischemic retinopathies. In particular, it has been shown that retinal microvascular degeneration is associated with increased expression of endothelial nitric oxide synthase (eNOS) [15] [16] [17] , increased generation of nitrites, nitrates and peroxynitrite, and protein tyrosine nitration [16] [17] [18] [19] , and can be prevented by pharmacological inhibition of NOS 16, 18 or deletion of Nos3, which encodes eNOS 18 . The mechanisms by which NO -derived reactive species participate in microvascular injury, however, are not fully characterized. We previously described a peroxidation process mediated by NO 2 that results in cis-trans-isomerization of arachidonic acid. This reaction produces four stable trans-arachidonic acid (TAA) monoisomers, 5E-AA, 8E-AA, 11E-AA and 14E-AA 20 , two of them (5E-AA and 8E-AA) being endogenous and not found in diet 21 . Furthermore, we showed in a model of septic shock that isomerization of arachidonic acid by NO 2 occurs in vivo 22 . Thus far, the pathological relevance and specific biological effects of these TAAs are unknown. We reasoned that the increased nitrative stress upon oxygen exposure in OIR 16, 18 may predispose to isomerization of arachidonic acid, and therefore investigated the generation of TAAs in an oxygen-induced model of microvascular degeneration and their influence on retinal vasculature and endothelial cell signaling and survival.
RESULTS
TAAs increase after nitrative stress NO 2 is a highly reactive free radical that originates in a number of ways in vivo, including through aerobic oxidation of NO (refs. 21, 23 ) and homolytic cleavage of peroxynitrite, which is formed by reaction of NO with superoxide (O 2 -) 21, 23, 24 . NO , O 2 -and 3-nitrotyrosine, markers of peroxynitrite-and NO 2 -induced nitration of proteins 23, 24 , are abundantly generated in endothelial cells exposed to hyperoxia 15 and in oxygen-induced retinopathy 16, 18 . To evaluate the hypothesis that these conditions may favor isomerization of arachidonic acid, we exposed postnatal day (P) 7 rat and mouse pups to 75-80% oxygen or room air for 24 h, and measured TAA levels in the retinas. Hyperoxia led to a significant increase in the concentration of free (unesterified to phospholipids, P o 0.001, n ¼ 6-13 animals per group) as well as total (free plus phospholipid-bound, P o 0.01, n ¼ 3-4 animals per group) TAA, reaching levels of 1.65 mM and 4.72 mM, respectively, in O 2 -exposed retinas (calculated from estimated retinal volumes; Fig. 1a,b) . To ascertain that the TAAs originated from an NO -dependent pathway, we treated oxygen-exposed animals with the specific NO synthase (NOS) inhibitor N-nitro-L-argininemethylester (L-NAME) 18 . Intraocular injection of L-NAME before oxygen exposure prevented the increase in TAA levels (Fig. 1a) , indicating that their formation depends on NO and ensuing nitrative stress in this model. Because eNOS is mainly responsible for the generation of nitrative stress in hyperoxia 16, 18 , as neuronal NOS does not increase and inducible NOS is not expressed 16 , we tested the contribution of eNOS on generation of TAAs in this model of microvasculopathy using C57BL/6 mice with a disrupted Nos3 gene. TAA levels did not increase in retinas of Nos3 -/-mice in contrast to their wild-type counterparts (Fig. 1b) .
TAAs inhibit angiogenesis and induce vaso-obliteration
We next evaluated the hypothesis that the nitrative stress-evoked increase in TAA concentrations could be involved in the retinal microvascular damage observed in OIR. Concordant with the observations on changes in TAA concentrations in OIR and the role of eNOS presented above, we corroborated that NOS inhibition (using L-NAME in rats) preserves retinal vasculature in the model of oxygeninduced vaso-obliteration in oxygen-exposed rat pups ( Fig. 1c , P o 0.01). Using concentrations of TAAs in the same range as those found in OIR (Fig. 1a) , we determined their effects on physiologic retinal vascularization in vivo as well as ex vivo on retinal explants. In rodents, retinal angiogenesis starts soon after birth 25 , and superficial microvessels reach the edges of the retina by P9 (ref. 25) . We assessed the effects of TAAs on normal angiogenesis using intraocular injections in P6 rat pups. Eyes injected with TAAs showed a reduced vascularized retinal area (P o 0.01, n ¼ 14 eyes per group from three different experiments) and vascular density (P o 0.01) compared to vehicletreated eyes, clearly showing that TAAs hinder physiological angiogenesis and cause vaso-obliteration (Fig. 1d) , similar to the changes observed in the hyperoxic models 16, 18, 26 . To investigate the effects of TAAs on microvascular degeneration in situ, we exposed newborn pig retinal explants 27 to TAAs and assessed vascular density. Again, exposure to TAAs resulted in a significant decrease in vascular density compared to controls (P o 0.001, n ¼ 14-15 explants per group from three separate experiments; Fig. 1e ).
TAAs induce selective cell death by apoptosis
To clarify the cell-type susceptibility thought to be involved in microvascular degeneration, we assessed effects of TAAs on the survival of different types of cultured neuromicrovascular cells. TAAs induced a concentration-and time-dependent microvascular endothelial cell death ( Fig. 2a,b ; EC 50 at 24 h: 3-8 mM, consistent with in vivo concentrations; Fig. 1b,c) ; concentrations of TAAs within this range were used thereafter. In contrast, smooth muscle, human umbilical vein endothelial cells (HUVECs) and astrocytes were unaffected by exposure to TAAs (Fig. 2c-e) , suggesting that TAAs specifically lead to microvascular endothelial cell death. We examined the nature of microvascular endothelial cell death using TUNEL staining for detection of nuclear DNA fragmentation and a caspase chromogenic substrate to detect caspase activity, both of which are hallmarks of apoptosis. DNA fragmentation (P o 0.0001) and caspase activity (P o 0.0001) were significantly increased in endothelial cells treated with TAAs ( Fig. 2f,g ), indicative of apoptotic endothelial cell death. Consistently, the nuclear morphology of Hoechst-stained endothelial cells treated with TAAs was altered, showing a pycnotic appearance in TUNEL-positive cells (Fig. 2g) .
TAAs induce apoptosis through upregulation of TSP-1
To investigate the mechanisms underlying TAA-induced endothelial cell apoptosis, we first determined whether arachidonic acid metabolic pathways 2 are involved; notably, roles for leukotrienes and prostanoids in angiogenesis and microvascular damage are well documented 2, 28, 29 . Inhibition of cyclooxygenase 1, cyclooxygenase 2 and leukotriene receptor did not prevent TAA-induced cell death ( Supplementary  Fig. 1 online) . TAAs only slightly increased concentrations of thromboxane ( Supplementary Fig. 1 online), reported to exert retinovascular endothelial cytotoxicity 28 ; correspondingly, inhibitors of thromboxane A 2 synthase and receptor did not affect TAA-induced endothelial cell death ( Supplementary Fig. 1 online) . Agonists of prostanglandin I 2 and E 2 receptors, previously shown to possess prosurvival properties 2, 29 , did not counter the cytotoxic effects of TAAs ( Supplementary Fig. 1 online) . Furthermore, inhibition of the cytochrome P450 monooxygenase pathway, which can metabolize TAAs 30 , did not influence TAA-evoked cytotoxicity ( Supplementary  Fig. 1 online) . Thus, pro-cell-death effects of TAAs seemed to be independent of classical major arachidonic acid metabolic pathways.
Because pro-and antiangiogenic factors have been shown to have an important role in the pathogenesis of oxygen-induced retinopathy 3 , we determined whether TAAs influenced their expression in endothelial cells. TAAs caused a rapid (within 2-6 h) increase in the expression of the antiangiogenic TSP-1 in cultured endothelial cells (Fig. 3a) .
Expression of VEGF receptor 2 (VEGFR2), shown to contribute to endothelial cell apoptosis and vessel loss in ischemic retinopathies [4] [5] [6] [7] , was found to exhibit a relatively delayed (B12 h) time-dependent decrease in response to TAA (Fig. 3a) . We investigated the effect of TSP-1 on VEGFR2 expression; TSP-1 depressed expression of VEGFR2 after exposure for 4 h, probably by inducing protease activation and its degradation 31 (Fig. 3b) . Therefore, the delayed decrease in expression of VEGRF2 is likely to occur secondarily to the TAA-induced upregulation of TSP-1. TSP-1 is a large matricellular protein that is synthesized and secreted by several cell types including endothelial cells 32 . TSP-1 inhibits angiogenesis by inducing microvascular endothelial cell apoptosis [31] [32] [33] and inhibiting the migration of these cells 32 . The ability of TSP-1 to trigger endothelial cell apoptosis requires the activation of its transmembrane receptor CD36 (refs. 34,35) and is essential to its antiangiogenic activity in vivo 35 . To establish a cause-and-effect relationship between TSP-1 upregulation and TAA-induced endothelial cell apoptosis, we used function-blocking antibodies directed against TSP-1 and CD36. Both TSP-1-specific antibody and antibody to CD36 that specifically blocks the TSP-1 binding site fully prevented TAA-induced endothelial cell death (Fig. 3c) ; in contrast, cell death elicited by TAAs was not altered by an antibody to CD36 that blocks the binding site of oxidized lowdensity lipoprotein (Fig. 3c) . We also tested the involvement of TSP-1 in retinal explants treated with TAAs. The vaso-obliterative effects of TAA under these conditions were prevented by both TSP-1-and CD36-specific antibodies (Fig. 4a) . To further corroborate the antiangiogenic role of TSP-1 and CD36 in response to TAAs, we tested the effects of TAAs on vascular sprouting from Matrigel-embedded aortic rings isolated from TSP-1-and CD36-knockout mice; sprouting aortic endothelium (von Willebrand factor (vWF) positive) contained immunoreactivity to CD36 (Fig. 4b) . TAAs interfered with vascular sprouting in aortas of wild-type mice, whereas this effect was virtually undetected in aortas of mice with disruptions in the genes encoding TSP-1 and CD36 ( Fig. 4b, P o 0.01 ). In line with these observations, the absence of an effect of TAAs on HUVECs (Fig. 2d) is consistent with their lack of CD36 receptors 36 . Taken together, the increase in TSP-1 expression observed before endothelial cell death, the apoptotic nature of endothelial cell death induced by TAAs and abrogation of cytotoxic effects of TAAs with antibodies to either TSP-1 or CD36 as well as in mice deficient in these proteins strongly point to a TSP-1-dependent pathway.
We also conducted experiments to determine mechanisms underlying TAA-induced upregulation of TSP-1. Involvement of the mitogen-activated protein kinase (MAPK) pathway has been shown in many apoptotic processes 37 . Recent studies have indicated that a transient activation of ERK1/2 (also known as MAPK p42/44) contributes to induction of apoptosis in several cell types, whereas basal, sustained activity is required for the maintenance of cell survival 38, 39 . We found ERK1/2 to be transiently phosphorylated in response to exposure to TAAs in endothelial cells (Fig. 3d) . Furthermore, blockage of the MEKK-ERK1/2 pathway with the specific MAPK kinase inhibitor PD98059 markedly suppressed TAA-induced upregulation of TSP-1 as well as TAA-induced endothelial cell death (Fig. 3e,f) ; inhibition of the other two MAPK pathways involved in stress and inflammation, namely p38 and JNK, had no effect on these parameters (data not shown). Hence, ERK1/2 seems to be required for TAA signaling.
TAAs induce TSP-1 ensuing vaso-obliteration in vivo
Oxygen-induced retinopathy is associated with vaso-obliteration, resulting in part from nitrative stress 16, 18 (Fig. 1a) , which increases formation of TAAs 21, 22 (Fig. 1b,c) . TAAs in turn cause retinal endothelial degeneration in vitro, ex vivo and in vivo (Figs. 1d,e and 2a,f,g), through induction of TSP-1 (Figs. 3c and 4a,b) . We therefore investigated in this oxygen-induced model of ischemic retinopathy the involvement of TSP-1 and CD36 in microvascular degeneration. We first showed that intravitreal injection of TAAs indeed caused an upregulated expression of TSP-1 in vivo, which was specifically localized on the endothelium, as shown by immunohistochemistry (Fig. 5a) ; on the other hand, there was no change in the expression of total retinal VEGFR2 expression, which is found in numerous cell types at that stage of development 7 . An increase in TSP-1 expression (protein and mRNA) was also detected in retinas of rats and mice exposed to hyperoxia for 24 h (Fig. 5b,c) along with the rise in TAA levels (Fig. 1b,c) ; TSP-1 was localized on endothelium in this model also (Fig. 5d) . Correspondingly, this increase in TSP-1 (Tsp1 mRNA expression detected by quantitative PCR and corrected for that of Vwf) was significantly attenuated in Nos3 -/-compared to wild-type oxygen-exposed mice ( Fig. 5c ; P o 0.01, n ¼ 6 per group). Finally, to verify that oxygen-induced changes in TAAs (Fig. 1b,c) and ensuing upregulation of TSP-1 (Fig. 5b) are physiologically relevant, we studied retinal vascularization in hyperoxia-exposed mice deficient in CD36; vaso-obliteration was significantly attenuated in Cd36 -/- (Fig. 5e , P o 0.001, n ¼ 8 per group); a similar attenuation was reported in hyperoxia-exposed Tsp1 -/-mice 8 .
DISCUSSION
The recently described markers of nitrative stress and major products of NO 2 -mediated isomerization of arachidonic acid, TAAs, represent a new aspect of NO 2 -induced toxicity. We investigated whether and how endogenous TAAs contribute to endothelial cell degeneration. We found that TAAs are generated in vivo in an experimental model of oxygen-induced microvascular degeneration, reaching concentrations in the micromolar range. The nitrative stress dependency of TAA formation was shown by using the NOS inhibitor L-NAME and Nos3 -/-animals, which prevented the increase of TAAs upon exposure to oxygen and associated vaso-obliteration. Moreover, TAAs were found to induce microvascular endothelial cell death in vitro, ex vivo and in vivo. Previous studies have shown that isomerization of arachidonic acid occurs in vivo. TAAs are found to circulate as free acids in human plasma 40 and have been shown to increase in a model of septic shock 22 , a condition that is correlated with nitrative stress 41, 42 . Our data provide an additional pathological condition in which TAAs are generated in substantial amounts. We now show that these unique lipids are biologically active molecules and important contributing factors to microvascular damage as seen in ischemic retinopathies. This was demonstrated by showing that TAAs induce selective apoptosis of microvascular endothelial cells in vitro, and exert specific, species-independent cytotoxicity on retinal microvessels in both ex vivo and in vivo models.
In vivo, TAAs derive solely from the reaction of the radical NO 2 with arachidonic acid 21, 22 , probably involving the binding of NO 2 to arachidonic acid followed by a rearrangement of the nitroarachidonyl radical, loss of NO 2 and formation of a trans bond 21 . Thus, they are specifically produced under conditions associated with nitrative stress, such as inflammation and ischemia; this inference is supported in our study using pharmacological inhibitors of NOS and Nos3 -/-mice. Under these pathological conditions, NO -mediated cell death is thought to be caused by the reaction of NO -derived free radicals, in particular peroxynitrite, N 2 O 3 , and NO 2 , with biological targets such as DNA, lipids and proteins 13 . The proposed mechanisms include inactivation of mitochondrial respiration 43 , modulation of gene expression 44 , nitration of DNA and protein 13, 24 and peroxidation of lipids 13, 23 . Although all the previously described effects of NO -derived free radicals concentrated on direct modifications of target molecules such as protein and DNA, which may alter their function, no secondary signaling molecule has so far been identified. By showing that TAAs are released during nitrative stress and induce microvascular damage mediated by upregulation TSP-1 in retinal microvascular endothelial cells, our results identify TAAs as new mediators of nitrative stress in vivo and unravel a mechanism by which reactive nitrogen species contribute to microvascular degeneration in ischemic retinopathies. Because generation of NO -derived free radicals has been suggested to be involved in the pathophysiology of numerous diseases 41 , we propose that our findings could possibly be extrapolated to explain microvascular damage occurring in diabetes, ischemic encephalopathies and inflammation.
Our data indicate that TAA-induced cell death and microvascular degeneration are mediated by TSP-1; in addition, upregulation of the latter seems to depend on activation of ERK1/2. Although ERK1/2 is usually regarded as a cytoprotective kinase, whereas the two other main MAPKs, p38 and JNK, are generally considered to be mediators of cell death 37 , a transient activation of ERK1/2 has been shown to induce apoptosis, whereas sustained activity favors cell survival 38, 39 . Thus, our results provide additional evidence that ERK1/2 can have opposing effects on cell death and survival, depending on the kinetics and amplitude of its activation and the cellular environment, and provide new insight on the regulation of TSP-1 expression. Participation of TSP-1 in oxygen-induced microvascular injury has been shown by the demonstration that TSP-1-deficient mice are less susceptible to oxygen-induced vaso-obliteration 8 . In agreement with this finding, we found that retinal expression of TSP-1 is enhanced after 24 h of hyperoxia in OIR, before considerable vascular degeneration would normally be observed in this model 25 , and mice deficient in CD36 show less vaso-obliteration upon exposure to hyperoxia. Together, our data indicate TAA-induced expression of TSP-1 as an important pathway responsible for subsequent microvascular damage, and also provide evidence for a previously undescribed link between nitrative stress and TSP-1, notably involving ERK1/2. The signaling pathway leading from TAA-induced activation of MAPK to upregulation of TSP-1 remains undefined. We found that expression of p53 and PPARg, which are thought to be involved in regulation of TSP-1 (refs. 45,46), were not modulated by TAAs. On the other hand, previous studies suggest that trans-fatty acids alter cell membrane function by modifying its fluidity and permeability, leading to activation of membrane-bound channels and enzymes 21 . Nevertheless, the specificity of the effect of TAAs on expression of TSP-1 suggests that they might exert their effect through an as yet unknown receptor. Further characterization of the molecular mechanisms leading to TAA-evoked induction of TSP-1 is required and is currently under investigation.
The formation of TAAs is subject to the redox potential of the tissue. Accordingly, an immature subject would be more vulnerable as a result of its decreased antioxidant capacity [47] [48] [49] . We have recently shown that nitration, which leads to generation of TAAs 20 , occurs when the redox state of the developing tissue is shifted toward an oxidative environment 16 . Our current findings, primarily observed in newborn animals, concur with this inference. There is currently no available effective treatment to prevent microvascular damage in ischemic retinopathies and microangiopathies. By identifying a new mechanism of microvascular injury, our data provide new therapeutic strategies in these seriously debilitating diseases associated with nitrative stress. Thus, interventions targeting the formation of TAAs or NO 2 may have potential therapeutic applications in conditions such as ischemic retinopathies and other microangiopathies. Animal preparation and quantitation of retinal vascularization. We maintained P7 rat pups, Nos3 +/+ and Nos3 -/-mice, and Cd36 +/+ and Cd36 -/-mice of C57BL/6 background in room air or exposed them to 80% (rats) or 75% (mice) oxygen for 24 h (Oxycycler A82OCV, Biospherix) to generate an oxygen-induced retinopathy. We intravitreally injected rat pups with L-NAME (Sigma; 10 -5 M final intraocular concentration based on estimated eye volume 29 ) before exposure to oxygen. We intravitreally injected other rat pups at P6, P7 and P8 with either vehicle or 14E-AA (estimated final concentration of 5 Â 10 -6 M) 29 .
Explants of retinal tissue can be cultured for several days and retain their proliferation and differentiation capacities and their histological architecture 27 . We cultured retinas of newborn (1-2 d old) pigs for 3 d on a Nucleopore polycarbonate Track Etch membrane (pore size 0.03 mm, Whatman) placed on DMEM (Gibco) containing 1% FBS and 1% penicillin-streptomycin, in the presence or absence of 14E-AA (5 Â 10 -6 M), CD36-specific (clone FA6-152, 10 mg/ml, Immunotech) or TSP-1-specific (clone A4.1, 30 mg/ml, Neomarkers) antibodies. We performed immunohistochemistry for whole retinas and explants using thrombospondin Ab-3 antibody (1:100, Oncogene) and lectin Griffonia simplicifolia conjugated to TRITC (1:100, Sigma) as previously described 29 . We flat-mounted and photographed retinas and explants; we measured vascular density as capillary length per retinal surface area (mm/mm 2 ); we measured vascularized areas and expressed them as percent of total retinal area 16, 29 .
TAA measurement. We dissected retinas and placed them into a 1:1 chloroform/methanol solution containing butylated hydroxytoluene to extract lipids.
We measured TAA (both esterified to lipids and free) content by mass spectrometry analysis 20, 21 and normalized it to protein content.
Cell cultures. We cultured endothelial cells and astrocytes from newborn pig brain and retina 28, 50 . We purchased VSMCs and HUVECs from Clonetics.
Assessment of cell viability. We exposed cells to each TAA for 24 h at indicated concentrations or to 14E-AA (5 Â 10 -6 M) for different durations and assessed cell viability by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide, Sigma) assay 28 . In another set of experiments, we pretreated cells with TSP-1-specific antibody (clone A4.1, 30 mg/ml, Neomarkers), CD36-specific antibodies (clones FA6-152 (which blocks TSP-1 binding), 10 mg/ml, Immunotech, and JC63.1 (which blocks binding of oxidized low-density lipoprotein), 2 mg/ml, Cayman Chemicals) and PD98059 (MEKK inhibitor, 10 -5 M, Calbiochem) 30 min before exposing them to 14E-AA (5 Â 10 -6 M) for 24 h. We calculated cell viability as percent of control values.
Apoptosis assays. We cultured endothelial cells for 18 h in the presence or absence of 14E-AA (5 Â 10 -6 M). We performed detection of DNA fragmentation with a commercial kit based on TUNEL (TACS TdT kit, R&D Systems). We assessed caspase activity using a commercial kit (Sulforhodamine Multicaspase Activity kit, Biomol Research Laboratories). We calculated values as positive cells as a percent of total cells.
Western blots. We exposed lysates of endothelial cells to 14E-AA (5 Â 10 -6 M) in the presence or absence of PD98059 (10 -5 M) or to TSP-1 (10 -7 M, provided by H. Ong, Université de Montréal) and we used the membrane fraction of rat pup retinas for western blot analysis of protein expression 28 . We used the following antibodies: monoclonal TSP-1-specific (clone Ab-1, 1:400, Oncogene), VEGFR2-specific (1:250, Chemicon International), polyclonal ERK 1/2-and phosphorylated ERK 1/2-specific (1:5,000, Promega), and monoclonal b-actin-specific (1:60,000, Abcam).
Microvascular sprouting from aortic explants. We prepared aortae from 10-week-old male C57BL/6 wild-type, Tsp1 -/-and Cd36 -/-mice of the same background. We covered aortic rings with 50 ml Matrigel and cultured them for 4 d in EGM-2 medium (Clonetics). We exposed explants to 14E-AA (5 Â 10 -6 M) from day 4 to 6 of culture. We took photomicrographs of individual explants at day 4 and day 6 and measured microvascular sprouting as the surface covered at day 6 minus that at day 4. We characterized outgrowing cells by double-labeling them with monoclonal vWF-specific (1:100, Dako) and polyclonal CD36-specific (1:100, Santa Cruz) antibodies after acetone fixation.
Real-time quantitative RT-PCR. We exposed Nos3 +/+ and Nos3 -/-mice of C57BL/6 background to 75% oxygen from P7 to P8. We dissected retinas and performed RNA extraction using the Qiagen RNA extraction kit (Qiagen). For cDNA synthesis, we used 2 mg mRNA in all reactions. We performed real-time quantitative PCR on MJ4000 and MJ3005 thermocyclers (Stratagene), using 5¢-GTTTGTGCAGCAGAGGAACA-3¢ and 5¢-CATTCACCCTGGCTCTTCTC-3¢ for Vwf and 5¢-GCCATGTCCTCTCACAGGGC-3¢ and 5¢-CTGTGGCCACTGG GAGATTAGC-3¢ for Tsp1. We standardized RNA levels to parallel measurements of S16 RNA.
Data analysis. Data were analyzed by Kruskall-Wallis and Mann-Whitney tests according to the number of groups compared. P o 0.05 was considered to be statistically significant. 
